Login / Signup

Lower starting dose of roxadustat in non-dialysis-dependent chronic kidney disease patients with anaemia: a study protocol for a randomised, multicentre, open-label study.

Ping LiXuefeng SunDinghua ChenHong-Li LinLi ZhangYiqing WuShuting PanGuang-Yan CaiXiangmei Chen
Published in: BMJ open (2023)
ChiCTR2100045359.
Keyphrases
  • chronic kidney disease
  • open label
  • clinical trial
  • end stage renal disease
  • study protocol
  • double blind
  • phase ii
  • phase iii
  • phase ii study
  • peritoneal dialysis
  • radiation therapy
  • placebo controlled
  • rectal cancer